Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
CANCER:
Meningioma
Associations
(8)
News
Trials
A2 | Sensitive
C3 | Sensitive
D | Sensitive
A2 | Resistant
C3 | Resistant
D | Resistant
Show legend
Group by Gene:
Include preclinical:
Drug categories
Tyrosine Kinase Inhibitors
Serine-Threonine Kinase Inhibitors
Other
Wnt Signaling Inhibitors
Cyclin Dependent Kinase Inhibitors
CD Protein Inhibitors
Cancel
SSTR agonist
DG3173
VEGF-A inhibitor
bevacizumab
VEGF-A inhibitor, mTOR inhibitor
bevacizumab + everolimus
Hedgehog cell-signalling pathway inhibitor
vismodegib
FAK inhibitor
GSK2256098
VEGFR inhibitor, PDGFR inhibitor, c-KIT inhibitor
sunitinib
mTOR inhibitor
temsirolimus
CDK4 inhibitor, CDK6 inhibitor
palbociclib
No biomarker
A2
No biomarker
|
Meningioma
|
DG3173
A2
No biomarker
|
Meningioma
|
bevacizumab
A2
No biomarker
|
Meningioma
|
bevacizumab + everolimus
A2
No biomarker
|
Meningioma
|
sunitinib
SMO P641A
C3
SMO P641A
|
Meningioma
|
vismodegib
NF2 mutation
C3
NF2 mutation
|
Meningioma
|
GSK2256098
RB1 mutation
D
RB1 mutation
|
Meningioma
|
palbociclib
KLF4 K409Q
D
KLF4 K409Q
|
Meningioma
|
temsirolimus
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
